|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/7088 | (2006.01) |
| A61K 31/7068 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1763356 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05738307.7 |
| Date of filing the European patent application | 2005-04-15 | |
| (97) | Date of publication of the European application | 2007-03-21 |
| (45) | Date of publication and mention of the grant of the patent | 2008-07-16 |
| (46) | Date of publication of the claims translation | 2008-11-27 |
| (86) | Number | PCT/US2005/012968 |
| Date | 2005-04-15 |
| (87) | Number | WO 2005/107771 |
| Date | 2005-11-17 |
| (30) | Number | Date | Country code |
| 564540 P | 2004-04-22 | US |
| (72) |
PATEL, Bharvin, Kumar, US
|
| (73) |
ELI LILLY AND COMPANY,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Kompozicija, apimanti survivino antisensinį oligonukleotidą ir gemcitabiną, skirta vėžio gydymui |
| COMPOSITION COMPRISING A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND GEMCITABINE FOR THE TREATMENT OF CANCER |
| Payment date | Validity (years) | Amount | |
| 2012-03-28 | 8 | 640.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2013-04-15 |